Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 24;2(2):99-108.
doi: 10.1021/acscentsci.5b00331. Epub 2016 Jan 20.

Metabologenomics: Correlation of Microbial Gene Clusters with Metabolites Drives Discovery of a Nonribosomal Peptide with an Unusual Amino Acid Monomer

Affiliations

Metabologenomics: Correlation of Microbial Gene Clusters with Metabolites Drives Discovery of a Nonribosomal Peptide with an Unusual Amino Acid Monomer

Anthony W Goering et al. ACS Cent Sci. .

Abstract

For more than half a century the pharmaceutical industry has sifted through natural products produced by microbes, uncovering new scaffolds and fashioning them into a broad range of vital drugs. We sought a strategy to reinvigorate the discovery of natural products with distinctive structures using bacterial genome sequencing combined with metabolomics. By correlating genetic content from 178 actinomycete genomes with mass spectrometry-enabled analyses of their exported metabolomes, we paired new secondary metabolites with their biosynthetic gene clusters. We report the use of this new approach to isolate and characterize tambromycin, a new chlorinated natural product, composed of several nonstandard amino acid monomeric units, including a unique pyrrolidine-containing amino acid we name tambroline. Tambromycin shows antiproliferative activity against cancerous human B- and T-cell lines. The discovery of tambromycin via large-scale correlation of gene clusters with metabolites (a.k.a. metabologenomics) illuminates a path for structure-based discovery of natural products at a sharply increased rate.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Work and data flows for a “metabologenomics” approach to natural products discovery from bacteria. Using information obtained from interpreting 178 sequenced genomes into gene clusters and gene cluster families (top center panel, described in ref (8)) and from MS-based metabolomics of the same 178 strains with accurate mass (bottom center panel), pairwise correlation yields scores that associate metabolites with their gene cluster families (panel at right).
Figure 2
Figure 2
Structures of JBIR34 and 35 (A), tambromycin (B), and key NMR correlations (C). Structure of tambromycin is shown with the new amino acid residue tambroline highlighted in panel (B). The related structures JBIR 34 and 35 are shown in panel (A). Panel (C) highlights key correlations derived from 1H-1H COSY, 1H-1H NOESY, and 1H-13C HMBC experiments. 1H-13C HMBC correlations from the indole 2-position proton and 2-methyl-serine methylene protons to the same carbonyl carbon were used to determine the connectivity of these substructures as a methyl-oxazoline. Another important 1H-13C HMBC correlation from the alpha proton of tambroline to the carbonyl carbon of 2-methyl-serine associated these two substructures. These correlations and the overall sequence of the peptide were confirmed by tandem mass spectrometry (Figure S5). 1H-1H COSY correlations across the continuous spin system present in the pyrrolidine substructure are shown as widened bonds.
Figure 3
Figure 3
Distribution of the tambromycin gene cluster across diverse Streptomycetes. (A) The biosynthetic gene cluster of tambromycin is—with one exception—distributed throughout the Streptomyces virginiae clade (www.igb.illinois.edu/labs/metcalf/gcf/gcfDisplay.php?gcf=NRPS_GCF.519). (B) Eighteen strains within the virginiae clade were identified as having a member of this GCF. The plurality of strains containing a member of this gene cluster family made it possible to draw precise gene cluster boundaries from the ORFs that are conserved across all members of this group.
Figure 4
Figure 4
Overview of the tambromycin biosynthetic gene cluster. Organization of the tambromycin biosynthetic gene cluster is shown. ORFs and protein representations are color coordinated with the structure of tambromycin to indicate their proposed association with biosynthesis of a particular amino acid substructure. Proteins colored gray are not proposed to be involved directly in biosynthesis, but rather in cluster regulation, transport, or other supporting roles (e.g., phosphopantetheinylation of NRPS proteins).
Figure 5
Figure 5
Summary of stable isotope feeding experiments and biosynthetic insights. (A) Stable isotope experiments were carried out by feeding labeled lysine, tryptophan, and alanine. When strain F-4474 was cultured with tryptophan-d3, tambromycin was observed to incorporate three deuterons from the indole portion of the tryptophan label into its structure, consistent with two substitutions occurring on the indole ring. Tambromycin also appeared to incorporate two 13C alanine monomers, which are modified via a hydroxymethyltransferase to form 2-methyl-serine. (B) Summary of heavy isotopes observed to be incorporated into the structure of tambromycin. (C) Lysine labeled with no heavy isotopes (panel at far left) deuterium, 13C and 15N (at the indicated positions in each panel) was used to illuminate the biosynthetic path leading to the formation of tambroline by comparing the change in mass of a tambroline-derived internal fragment ion observed in the MS2 spectrum of tambromycin. (D) Proposal for a biosynthesis of tambroline from lysine through an acyl-CoA dehydrogenase-catalyzed mechanism consistent with the labeling results shown in C).

Similar articles

Cited by

References

    1. Cragg G. M.; Newman D. J. Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta, Gen. Subj. 2013, 1830 (6), 3670–3695. 10.1016/j.bbagen.2013.02.008. - DOI - PMC - PubMed
    2. Newman D. J.; Cragg G. M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70 (3), 461–477. 10.1021/np068054v. - DOI - PubMed
    1. Jones D.; Metzger H. J.; Schatz A.; Waksman S. A. Control of Gram-Negative Bacteria in Experimental Animals by Streptomycin. Science 1944, 100 (2588), 103–105. 10.1126/science.100.2588.103. - DOI - PubMed
    1. Arcamone F.; Cassinelli G.; Fantini G.; Grein A.; Orezzi P.; Pol C.; Spalla C. Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol. Bioeng. 1969, 11 (6), 1101–1110. 10.1002/bit.260110607. - DOI - PubMed
    1. Bachmann B. O.; Van Lanen S. G.; Baltz R. H. Microbial genome mining for accelerated natural products discovery: is a renaissance in the making?. J. Ind. Microbiol. Biotechnol. 2014, 41 (2), 175–184. 10.1007/s10295-013-1389-9. - DOI - PMC - PubMed
    1. Bentley S. D.; Chater K. F.; Cerdeno-Tarraga A. M.; Challis G. L.; Thomson N. R.; James K. D.; Harris D. E.; Quail M. A.; Kieser H.; Harper D.; Bateman A.; Brown S.; Chandra G.; Chen C. W.; Collins M.; Cronin A.; Fraser A.; Goble A.; Hidalgo J.; Hornsby T.; Howarth S.; Huang C. H.; Kieser T.; Larke L.; Murphy L.; Oliver K.; O’Neil S.; Rabbinowitsch E.; Rajandream M. A.; Rutherford K.; Rutter S.; Seeger K.; Saunders D.; Sharp S.; Squares R.; Squares S.; Taylor K.; Warren T.; Wietzorrek A.; Woodward J.; Barrell B. G.; Parkhill J.; Hopwood D. A. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 2002, 417 (6885), 141–147. 10.1038/417141a. - DOI - PubMed
    2. Oliynyk M.; Samborskyy M.; Lester J. B.; Mironenko T.; Scott N.; Dickens S.; Haydock S. F.; Leadlay P. F. Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338. Nat. Biotechnol. 2007, 25 (4), 447–453. 10.1038/nbt1297. - DOI - PubMed
    3. Udwary D. W.; Zeigler L.; Asolkar R. N.; Singan V.; Lapidus A.; Fenical W.; Jensen P. R.; Moore B. S. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (25), 10376–10381. 10.1073/pnas.0700962104. - DOI - PMC - PubMed

LinkOut - more resources